CIEC
PFE icon

Crédit Industriel et Commercial’s Pfizer PFE Stock Holding History

Crédit Industriel et Commercial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$820K Buy
34,071
+15,866
+87% +$415K 0.05% 218
2026
Q1 		$511K Sell
18,205
-16,468
-47% -$438K 0.04% 246
2025
Q4 		$863K Sell
34,673
-10,436
-23% -$263K 0.07% 236
2025
Q3 		$1.15M Buy
+45,109
New +$1.11M 0.1% 197

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Crédit Industriel et Commercial's PFE Position: Q2 2026 in Review

Crédit Industriel et Commercial increased its Pfizer (PFE) stake by 87% in Q2 2026, buying an estimated $415K and bringing the position to 34,071 shares worth $820K. The position accounts for 0.05% of the portfolio, ranked #218.

Crédit Industriel et Commercial first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.15M in Q3 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Crédit Industriel et Commercial held 34,071 shares of Pfizer worth $820K as of Q2 2026.
  • Crédit Industriel et Commercial bought 15,866 Pfizer shares in Q2 2026, an estimated $415K.
  • Pfizer made up 0.05% of Crédit Industriel et Commercial's portfolio in Q2 2026, its #218 holding.
  • Crédit Industriel et Commercial first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • Crédit Industriel et Commercial's Pfizer position peaked at $1.15M in Q3 2025.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.